SULFUR

SULFUR was reported 8386 times

SULFUR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STAPHYLOCOCCUS TEST NEGATIVE 1 0.1250
1 SKIN FRAGILITY 162 0.0665
2 JOINT VIBRATION 1 0.0476
3 FIRST DEGREE CHEMICAL BURN OF SKIN 1 0.0417
4 ACNE CYSTIC 104 0.0345
5 ACNE 2256 0.0297
6 SKIN BURNING SENSATION 2016 0.0281
7 SKIN IRRITATION 1265 0.0276
8 SEBORRHOEA 98 0.0267
9 PAIN OF SKIN 633 0.0235
10 CHEMICAL BURN 27 0.0234
11 ALLERGY TO SURGICAL SUTURES 1 0.0233
12 LOWER RESPIRATORY TRACT INFECTION VIRAL 11 0.0217
13 CHEMICAL BURN OF SKIN 54 0.0213
14 ACNE PUSTULAR 17 0.0207
15 DRY SKIN 2549 0.0191
16 SKIN HYPERPIGMENTATION 163 0.0189
17 BURSAL FLUID ACCUMULATION 1 0.0185
18 STAPHYLOCOCCAL IMPETIGO 1 0.0175
19 SKIN HYPOPIGMENTATION 29 0.0164
20 SKIN DISCOMFORT 44 0.0163
21 SKIN EXFOLIATION 1152 0.0136
22 RASH FOLLICULAR 2 0.0130
23 RASH PAPULAR 283 0.0126
24 SENSITIVE SKIN 85 0.0115
25 LUNG ADENOCARCINOMA STAGE III 1 0.0115
26 DILATED PORES 1 0.0110
27 SKIN SWELLING 95 0.0109
28 SKIN TIGHTNESS 50 0.0106
29 CYST DRAINAGE 1 0.0104
30 ACNE FULMINANS 2 0.0102
31 ERYTHEMA 2047 0.0099
32 PERIORBITAL INFLAMMATION 2 0.0087
33 ONYCHOMALACIA 1 0.0080
34 ENTEROCOLONIC FISTULA 1 0.0075
35 APPLICATION SITE ODOUR 1 0.0069
36 EYELID EXFOLIATION 5 0.0063
37 GASTRIC MUCOSA ERYTHEMA 2 0.0060
38 ENDOMETRIAL CANCER STAGE I 1 0.0060
39 RASH MACULAR 202 0.0058
40 SKIN FISSURES 107 0.0055
41 DERMATITIS 114 0.0054
42 SCAR 93 0.0054
43 SKIN INJURY 18 0.0054
44 SCAB 61 0.0053
45 SKIN EROSION 16 0.0050
46 CONNECTIVE TISSUE DISORDER 7 0.0049
47 SKIN WARM 28 0.0048
48 SKIN REACTION 67 0.0048
49 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 331 0.0046
50 EXPOSURE VIA INHALATION 1 0.0046
51 ECZEMA ASTEATOTIC 2 0.0042
52 ROSACEA 19 0.0041
53 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 29 0.0040
54 DEVICE ALLERGY 1 0.0040
55 URTICARIA PAPULAR 1 0.0039
56 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 1 0.0037
57 SKIN WRINKLING 10 0.0037
58 UNDERDOSE 267 0.0037
59 SKIN HAEMORRHAGE 49 0.0033
60 EYELID SKIN DRYNESS 4 0.0033
61 EYELID IRRITATION 8 0.0032
62 LIP DISCOLOURATION 4 0.0032
63 SKIN TEXTURE ABNORMAL 3 0.0031
64 SUNBURN 23 0.0031
65 IODINE ALLERGY 1 0.0030
66 DERMOID CYST 1 0.0030
67 ECTROPION 1 0.0030
68 TOOTH DEPOSIT 1 0.0029
69 SKIN DISCOLOURATION 129 0.0028
70 LID SULCUS DEEPENED 1 0.0027
71 ALBUMIN URINE PRESENT 1 0.0026
72 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 455 0.0025
73 LIP ERYTHEMA 2 0.0025
74 ALLERGY TO CHEMICALS 3 0.0024
75 RASH ERYTHEMATOUS 115 0.0024
76 OVERDOSE 516 0.0024
77 EYELID INFECTION 1 0.0023
78 POST INFLAMMATORY PIGMENTATION CHANGE 1 0.0022
79 HYPERGAMMAGLOBULINAEMIA 1 0.0021
80 EYELID RASH 2 0.0020
81 DERMAL CYST 5 0.0020
82 ARTIFICIAL CROWN PROCEDURE 1 0.0020
83 ROOT CANAL INFECTION 1 0.0020
84 FURUNCLE 16 0.0020
85 CAPILLARY FRAGILITY 1 0.0020
86 FOOD INTOLERANCE 7 0.0019
87 RASH 821 0.0019
88 SWELLING FACE 120 0.0018
89 HYPERAMYLASAEMIA 1 0.0018
90 ACARODERMATITIS 2 0.0018
91 SENSATION OF HEAVINESS 7 0.0018
92 EYE SWELLING 67 0.0018
93 PERFUME SENSITIVITY 1 0.0018
94 LYMPHOCYTE MORPHOLOGY ABNORMAL 1 0.0017
95 EYE BURNS 1 0.0017
96 HYPERSENSITIVITY 315 0.0017
97 PRURITUS 651 0.0017
98 MUSCLE FATIGUE 7 0.0017
99 ALLERGY TO METALS 1 0.0016
100 PROLONGED LABOUR 1 0.0016
101 LIP EXFOLIATION 2 0.0015
102 BONE DEFORMITY 1 0.0015
103 MACULAR HOLE 2 0.0015
104 SKIN INDURATION 3 0.0014
105 ANGULAR CHEILITIS 1 0.0014
106 LIP EROSION 1 0.0014
107 EXPOSURE TO COMMUNICABLE DISEASE 1 0.0013
108 OESOPHAGEAL DISCOMFORT 1 0.0013
109 PULMONARY MYCOSIS 1 0.0013
110 BLISTER 72 0.0013
111 STOMACH MASS 1 0.0013
112 LEUKOCYTOCLASTIC VASCULITIS 2 0.0012
113 INFECTED BITE 1 0.0012
114 SKIN WOUND 2 0.0012
115 MILIARIA 2 0.0012
116 SKIN INFECTION 13 0.0012
117 TRANSFUSION REACTION 1 0.0011
118 THERMAL BURN 8 0.0011
119 APPLICATION SITE DISCOMFORT 2 0.0011
120 ERYTHEMA OF EYELID 6 0.0011
121 INCISION SITE INFECTION 1 0.0011
122 OVARIAN CYST 11 0.0011
123 RASH PUSTULAR 8 0.0011
124 CONTRAST MEDIA ALLERGY 2 0.0011
125 DRUG INEFFECTIVE 1428 0.0011
126 URTICARIA 181 0.0011
127 BONE GRAFT 1 0.0011
128 LIP DISORDER 2 0.0011
129 RHEUMATOID LUNG 1 0.0010
130 EYELID MARGIN CRUSTING 3 0.0010
131 CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0010
132 BONE MARROW OEDEMA 1 0.0010
133 EYELIDS PRURITUS 3 0.0010
134 BURNS THIRD DEGREE 1 0.0009
135 TENDON PAIN 7 0.0009
136 CHAPPED LIPS 4 0.0009
137 SUPERFICIAL INJURY OF EYE 1 0.0009
138 SUBRETINAL FLUID 1 0.0009
139 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
140 ADVERSE REACTION 12 0.0009
141 DANDRUFF 2 0.0009
142 PRODUCT USE IN UNAPPROVED INDICATION 223 0.0009
143 SKIN ABRASION 4 0.0008
144 RASH VESICULAR 4 0.0008
145 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
146 HELICOBACTER GASTRITIS 1 0.0008
147 JOINT WARMTH 1 0.0008
148 SWELLING OF EYELID 5 0.0008
149 OBSTRUCTION GASTRIC 1 0.0008
150 APPLICATION SITE EROSION 1 0.0008
151 CONDITION AGGRAVATED 235 0.0008
152 PROTEIN TOTAL ABNORMAL 1 0.0008
153 HYPOVITAMINOSIS 1 0.0008
154 SKIN MASS 5 0.0007
155 B-LYMPHOCYTE COUNT DECREASED 1 0.0007
156 SKIN DEPIGMENTATION 1 0.0007
157 DISCHARGE 1 0.0007
158 CHRONIC FATIGUE SYNDROME 1 0.0007
159 SKIN HYPERTROPHY 2 0.0007
160 GLUTEN SENSITIVITY 1 0.0007
161 VASCULAR INJURY 1 0.0007
162 ADHESION 1 0.0007
163 RUBBER SENSITIVITY 1 0.0007
164 EYE ALLERGY 1 0.0006
165 ANALGESIC DRUG LEVEL INCREASED 1 0.0006
166 RESPIRATORY ALKALOSIS 1 0.0006
167 SEBORRHOEIC DERMATITIS 1 0.0006
168 TYMPANIC MEMBRANE PERFORATION 1 0.0006
169 EYE IRRITATION 33 0.0006
170 BURNS SECOND DEGREE 1 0.0006
171 CYST 7 0.0006
172 ECZEMA 29 0.0006
173 RASH PRURITIC 29 0.0005
174 GASTRIC INFECTION 2 0.0005
175 EYELID OEDEMA 6 0.0005
176 VULVOVAGINAL MYCOTIC INFECTION 2 0.0005
177 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
178 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
179 EYELID PAIN 1 0.0005
180 BREAST DISORDER 1 0.0005
181 LIP SWELLING 16 0.0005
182 SCRATCH 5 0.0005
183 PURULENT DISCHARGE 2 0.0005
184 SKIN ULCER 12 0.0005
185 LACRIMATION INCREASED 14 0.0005
186 OLIGOMENORRHOEA 1 0.0005
187 PARONYCHIA 2 0.0005
188 MENINGITIS ASEPTIC 2 0.0004
189 DRUG EFFECT DELAYED 2 0.0004
190 DERMATITIS CONTACT 5 0.0004
191 EYELID DISORDER 1 0.0004
192 BREAKTHROUGH PAIN 1 0.0004
193 PAPULE 3 0.0004
194 OCULAR HYPERAEMIA 20 0.0004
195 SUBCUTANEOUS ABSCESS 2 0.0004
196 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
197 BRONCHITIS CHRONIC 1 0.0004
198 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
199 INFREQUENT BOWEL MOVEMENTS 1 0.0004
200 DERMATITIS ALLERGIC 5 0.0004
201 URINARY TRACT INFECTION BACTERIAL 1 0.0004
202 EXCORIATION 1 0.0004
203 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
204 OVERWEIGHT 2 0.0004
205 PHOTOPHOBIA 7 0.0004
206 BRUXISM 2 0.0004
207 LIP BLISTER 1 0.0004
208 SKIN LESION 10 0.0004
209 NONSPECIFIC REACTION 2 0.0004
210 TRICHORRHEXIS 1 0.0004
211 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
212 PRODUCT USE ISSUE 67 0.0004
213 PERIORBITAL SWELLING 2 0.0004
214 JOINT LOCK 1 0.0004
215 LIP PAIN 1 0.0003
216 SKIN ATROPHY 2 0.0003
217 VITAMIN B12 DECREASED 1 0.0003
218 MUSCLE STRAIN 3 0.0003
219 MOUTH SWELLING 2 0.0003
220 HYPERTONIC BLADDER 1 0.0003
221 METABOLIC DISORDER 2 0.0003
222 GASTROINTESTINAL NECROSIS 1 0.0003
223 LIP DRY 3 0.0003
224 EMERGENCY CARE 1 0.0003
225 EYE PRURITUS 11 0.0003
226 MASTICATION DISORDER 1 0.0003
227 LYMPHOCYTE COUNT INCREASED 1 0.0003
228 MUSCLE TWITCHING 7 0.0003
229 PEPTIC ULCER 1 0.0003
230 ANXIETY DISORDER 1 0.0003
231 PARAESTHESIA 47 0.0003
232 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
233 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
234 LYMPHOEDEMA 2 0.0003
235 MICTURITION DISORDER 1 0.0003
236 LOGORRHOEA 1 0.0003
237 LYMPHADENOPATHY 10 0.0003
238 MACULOPATHY 1 0.0003
239 FACIAL BONES FRACTURE 1 0.0003
240 APPARENT DEATH 1 0.0003
241 ANAPHYLACTIC SHOCK 7 0.0003
242 SKIN DISORDER 9 0.0003
243 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
244 EYE INFECTION 3 0.0003
245 FRACTURE 5 0.0003
246 FACE INJURY 1 0.0003
247 GASTRIC HAEMORRHAGE 3 0.0003
248 FOOD ALLERGY 2 0.0003
249 WOUND SECRETION 1 0.0003
250 GASTROINTESTINAL INFLAMMATION 2 0.0003
251 ATRIAL FLUTTER 2 0.0003
252 FOREIGN BODY 1 0.0002
253 CANDIDIASIS 1 0.0002
254 VITAMIN B12 DEFICIENCY 1 0.0002
255 HYPERURICAEMIA 1 0.0002
256 SECRETION DISCHARGE 3 0.0002
257 VITAMIN D DECREASED 2 0.0002
258 CARDIAC OPERATION 2 0.0002
259 MELANOCYTIC NAEVUS 1 0.0002
260 GRIP STRENGTH DECREASED 2 0.0002
261 PANCREATITIS 12 0.0002
262 GINGIVAL SWELLING 1 0.0002
263 SWELLING 21 0.0002
264 HAIR TEXTURE ABNORMAL 3 0.0002
265 FACIAL PAIN 2 0.0002
266 ILEUS PARALYTIC 1 0.0002
267 IRON DEFICIENCY 1 0.0002
268 THROAT TIGHTNESS 6 0.0002
269 OSTEOMYELITIS 4 0.0002
270 HAEMOGLOBIN INCREASED 1 0.0002
271 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
272 INJECTION SITE PAPULE 1 0.0002
273 EYE OPERATION 1 0.0002
274 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
275 FEELING HOT 13 0.0002
276 LEUKAEMIA 2 0.0002
277 FUNGAL INFECTION 7 0.0002
278 MEDICATION RESIDUE PRESENT 1 0.0002
279 AUTOIMMUNE DISORDER 2 0.0002
280 HORMONE LEVEL ABNORMAL 1 0.0002
281 INCORRECT DOSAGE ADMINISTERED 1 0.0002
282 PROTEIN URINE PRESENT 1 0.0002
283 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
284 BLOOD COUNT ABNORMAL 3 0.0002
285 KLEBSIELLA INFECTION 1 0.0002
286 DIABETES MELLITUS 15 0.0002
287 PHARYNGEAL OEDEMA 3 0.0002
288 PERIPHERAL VASCULAR DISORDER 1 0.0002
289 RASH GENERALISED 5 0.0002
290 TENDERNESS 2 0.0002
291 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
292 PRODUCT RESIDUE PRESENT 1 0.0002
293 DECREASED ACTIVITY 2 0.0002
294 BURNING SENSATION 13 0.0002
295 ASTHENOPIA 1 0.0002
296 PHOTOSENSITIVITY REACTION 3 0.0002
297 HYPERKERATOSIS 1 0.0002
298 GASTRIC ULCER HAEMORRHAGE 1 0.0002
299 CHOLECYSTITIS ACUTE 1 0.0002
300 GENERALISED ERYTHEMA 1 0.0002
301 MYOCARDIAL ISCHAEMIA 2 0.0002
302 MICTURITION URGENCY 2 0.0002
303 RALES 1 0.0002
304 LOCAL SWELLING 3 0.0002
305 DECREASED INTEREST 1 0.0002
306 CATARACT OPERATION 1 0.0002
307 CYTOPENIA 2 0.0002
308 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
309 PIGMENTATION DISORDER 1 0.0002
310 EXPOSURE DURING PREGNANCY 10 0.0002
311 TOOTH EXTRACTION 2 0.0002
312 PRE-EXISTING CONDITION IMPROVED 1 0.0002
313 BLEPHAROSPASM 1 0.0002
314 FOREIGN BODY SENSATION IN EYES 1 0.0002
315 CARDIAC FLUTTER 1 0.0002
316 APPLICATION SITE VESICLES 1 0.0002
317 ANGINA UNSTABLE 1 0.0002
318 ORAL HERPES 3 0.0002
319 ABDOMINAL DISTENSION 16 0.0002
320 NODULE 2 0.0002
321 HYPOGAMMAGLOBULINAEMIA 1 0.0002
322 ABNORMAL LOSS OF WEIGHT 1 0.0001
323 CROHN'S DISEASE 1 0.0001
324 APPLICATION SITE RASH 2 0.0001
325 APPLICATION SITE REACTION 1 0.0001
326 DUODENAL ULCER 1 0.0001
327 HAND FRACTURE 1 0.0001
328 DRY EYE 7 0.0001
329 NEUTROPENIC SEPSIS 1 0.0001
330 FAECES SOFT 1 0.0001
331 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
332 DYSSTASIA 4 0.0001
333 MOUTH HAEMORRHAGE 1 0.0001
334 INFLAMMATION 7 0.0001
335 DRY MOUTH 11 0.0001
336 GLOSSODYNIA 3 0.0001
337 BOWEL MOVEMENT IRREGULARITY 1 0.0001
338 LIMB DISCOMFORT 4 0.0001
339 SWOLLEN TONGUE 4 0.0001
340 RENAL CYST 1 0.0001
341 MUSCULOSKELETAL STIFFNESS 11 0.0001
342 ABSCESS 2 0.0001
343 BLOOD DISORDER 1 0.0001
344 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
345 MUSCLE TIGHTNESS 2 0.0001
346 FIBROMYALGIA 3 0.0001
347 ASPHYXIA 1 0.0001
348 ADVERSE DRUG REACTION 11 0.0001
349 INFLUENZA LIKE ILLNESS 10 0.0001
350 HAIR DISORDER 1 0.0001
351 MUSCLE INJURY 1 0.0001
352 BREAST CANCER STAGE II 1 0.0001
353 LIVE BIRTH 1 0.0001
354 UNEVALUABLE EVENT 9 0.0001
355 CANDIDA INFECTION 2 0.0001
356 HEMIPARESIS 2 0.0001
357 INADEQUATE ANALGESIA 1 0.0001
358 GASTRIC DISORDER 4 0.0001
359 MYOPATHY 1 0.0001
360 CARDIAC MURMUR 1 0.0001
361 RHEUMATOID ARTHRITIS 13 0.0001
362 DRUG ERUPTION 2 0.0001
363 PATHOGEN RESISTANCE 1 0.0001
364 EXOSTOSIS 1 0.0001
365 ANAPHYLACTIC REACTION 6 0.0001
366 IRON DEFICIENCY ANAEMIA 1 0.0001
367 CONJUNCTIVITIS 2 0.0001
368 SPINAL DISORDER 1 0.0001
369 MUSCULOSKELETAL DISORDER 2 0.0001
370 FEELING JITTERY 2 0.0001
371 DRUG PRESCRIBING ERROR 2 0.0001
372 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
373 HYPERCHOLESTEROLAEMIA 1 0.0001
374 SURGERY 6 0.0001
375 PHARYNGEAL SWELLING 1 0.0001
376 INFLAMMATORY BOWEL DISEASE 1 0.0001
377 CATARACT 6 0.0001
378 SALIVARY HYPERSECRETION 1 0.0001
379 BRAIN INJURY 1 0.0001
380 ADVERSE EVENT 9 0.0001
381 EYE DISCHARGE 1 0.0001
382 POLLAKIURIA 4 0.0001
383 PRODUCT ODOUR ABNORMAL 1 0.0001
384 FOLLICULITIS 1 0.0001
385 INJECTION SITE DISCOMFORT 1 0.0001
386 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
387 MOUTH ULCERATION 2 0.0001
388 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
389 SKIN LACERATION 1 0.0001
390 WOUND INFECTION 1 0.0001
391 INJECTION SITE NODULE 1 0.0001
392 APPLICATION SITE PAIN 2 0.0001
393 TOOTH FRACTURE 1 0.0001
394 VISUAL ACUITY REDUCED 3 0.0001
395 FOOT DEFORMITY 1 0.0001
396 STEVENS-JOHNSON SYNDROME 2 0.0001
397 NERVE INJURY 1 0.0001
398 GASTROINTESTINAL DISORDER 8 0.0001
399 NEPHROPATHY TOXIC 1 0.0001
400 OCULAR DISCOMFORT 1 0.0001
401 APPLICATION SITE PRURITUS 2 0.0001
402 MYOCARDITIS 1 0.0001
403 MADAROSIS 1 0.0001
404 POST PROCEDURAL HAEMORRHAGE 1 0.0001
405 VASCULITIS 1 0.0001
406 BLOOD CHOLESTEROL INCREASED 4 0.0001
407 MIGRAINE 8 0.0001
408 CRYING 3 0.0001
409 SCHIZOPHRENIA 1 0.0001
410 NEURALGIA 2 0.0001
411 INJECTION SITE EXTRAVASATION 1 0.0001
412 ABASIA 2 0.0001
413 PHARYNGITIS 1 0.0001
414 ILEUS 1 0.0001
415 HAIR COLOUR CHANGES 1 0.0001
416 MEMORY IMPAIRMENT 11 0.0001
417 INJECTION SITE DISCOLOURATION 1 0.0001
418 HOT FLUSH 6 0.0001
419 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
420 PALPITATIONS 9 0.0001
421 APPLICATION SITE ERYTHEMA 2 0.0001
422 JOINT STIFFNESS 2 0.0001
423 GASTRITIS 2 0.0001
424 IMMUNE SYSTEM DISORDER 1 0.0001
425 PULMONARY CONGESTION 1 0.0001
426 EAR INFECTION 2 0.0001
427 EYE HAEMORRHAGE 1 0.0001
428 QUALITY OF LIFE DECREASED 1 0.0001
429 PALLOR 2 0.0001
430 HYPOAESTHESIA 11 0.0001
431 IMPAIRED GASTRIC EMPTYING 1 0.0001
432 ABDOMINAL PAIN UPPER 15 0.0001
433 CONTUSION 7 0.0001
434 PROCEDURAL PAIN 2 0.0001
435 MEDICATION ERROR 4 0.0001
436 ORAL DISCOMFORT 1 0.0001
437 WOUND 2 0.0001
438 MASS 1 0.0001
439 ALOPECIA 14 0.0001
440 BLINDNESS UNILATERAL 1 0.0001
441 EYE PAIN 4 0.0001
442 HEART RATE INCREASED 7 0.0001
443 IMPAIRED QUALITY OF LIFE 1 0.0001
444 APATHY 1 0.0001
445 THROAT IRRITATION 3 0.0001
446 HALLUCINATION 5 0.0001
447 THERAPEUTIC RESPONSE DECREASED 4 0.0001
448 MYALGIA 11 0.0001
449 DELUSION 1 0.0001
450 LUNG INFECTION 1 0.0001
451 BASAL CELL CARCINOMA 1 0.0001
452 BRAIN FOG 1 0.0001
453 BLOOD GLUCOSE INCREASED 12 0.0001
454 ARTHRITIS 5 0.0001
455 ULCER 1 0.0001
456 SCIATICA 1 0.0001
457 GAIT DISTURBANCE 12 0.0001
458 MALAISE 27 0.0001
459 PSORIASIS 8 0.0001
460 STAPHYLOCOCCAL INFECTION 2 0.0001
461 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
462 BLOOD PRESSURE DECREASED 4 0.0001
463 EXPIRED PRODUCT ADMINISTERED 2 0.0001
464 PERICARDITIS 1 0.0001
465 PAIN 36 0.0001
466 MUSCULOSKELETAL DISCOMFORT 1 0.0001
467 HEART RATE DECREASED 2 0.0001
468 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
469 HEAD DISCOMFORT 1 0.0001
470 ISCHAEMIC STROKE 1 0.0001
471 GOUT 1 0.0001
472 GASTROENTERITIS VIRAL 1 0.0001
473 DYSURIA 2 0.0001
474 FEELING ABNORMAL 13 0.0001
475 BLOOD GLUCOSE ABNORMAL 1 0.0001
476 DIZZINESS 27 0.0001
477 ARTHROPATHY 3 0.0001
478 HEPATIC STEATOSIS 1 0.0001
479 MIDDLE INSOMNIA 1 0.0001
480 GASTRIC ULCER 1 0.0001
481 INSOMNIA 14 0.0001
482 BLOOD PRESSURE INCREASED 8 0.0001
483 DRUG INTOLERANCE 5 0.0001
484 PRESCRIBED OVERDOSE 1 0.0001
485 EAR PAIN 1 0.0001
486 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
487 CHOKING 1 0.0001
488 KIDNEY INFECTION 1 0.0001
489 WHEEZING 3 0.0001
490 DISABILITY 1 0.0001
491 SINUS DISORDER 1 0.0001
492 UPPER LIMB FRACTURE 1 0.0001
493 SPINAL FRACTURE 1 0.0000
494 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
495 BODY TEMPERATURE INCREASED 1 0.0000
496 HAEMORRHAGE 5 0.0000
497 ROAD TRAFFIC ACCIDENT 2 0.0000
498 ABDOMINAL DISCOMFORT 8 0.0000
499 KNEE ARTHROPLASTY 1 0.0000
500 HALLUCINATION, VISUAL 1 0.0000
501 HYPERTENSION 10 0.0000
502 IRRITABLE BOWEL SYNDROME 1 0.0000
503 LIVER FUNCTION TEST INCREASED 1 0.0000
504 HYPERHIDROSIS 6 0.0000
505 SKIN CANCER 1 0.0000
506 PNEUMONIA 15 0.0000
507 BALANCE DISORDER 4 0.0000
508 SEPTIC SHOCK 2 0.0000
509 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
510 MELAENA 1 0.0000
511 ANGIOEDEMA 2 0.0000
512 HEADACHE 28 0.0000
513 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
514 PANCREATITIS ACUTE 1 0.0000
515 HEART RATE IRREGULAR 1 0.0000
516 HEPATIC ENZYME INCREASED 3 0.0000
517 NEPHROLITHIASIS 2 0.0000
518 PYREXIA 15 0.0000
519 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
520 MULTIPLE SCLEROSIS 2 0.0000
521 BLOOD PRESSURE FLUCTUATION 1 0.0000
522 HEPATIC CANCER 1 0.0000
523 PRESYNCOPE 1 0.0000
524 ARTHRALGIA 17 0.0000
525 INJECTION SITE URTICARIA 1 0.0000
526 BRONCHITIS 3 0.0000
527 ABDOMINAL PAIN LOWER 1 0.0000
528 HAEMATEMESIS 1 0.0000
529 FLUID RETENTION 2 0.0000
530 PERIPHERAL SWELLING 6 0.0000
531 ILLNESS 4 0.0000
532 DIPLOPIA 1 0.0000
533 NERVOUSNESS 2 0.0000
534 DEAFNESS 1 0.0000
535 SEDATION 1 0.0000
536 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
537 ASTHENIA 14 0.0000
538 DRUG EFFECT DECREASED 2 0.0000
539 DYSPNOEA 21 0.0000
540 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
541 DIVERTICULITIS 1 0.0000
542 MENTAL STATUS CHANGES 1 0.0000
543 NECK PAIN 2 0.0000
544 ASTHMA 4 0.0000
545 URINARY TRACT INFECTION 6 0.0000
546 INTENTIONAL DOSE OMISSION 1 0.0000
547 HYPERSOMNIA 1 0.0000
548 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
549 PANCREATIC CARCINOMA 1 0.0000
550 INFECTION 5 0.0000
551 BACK PAIN 8 0.0000
552 INTENTIONAL PRODUCT MISUSE 3 0.0000
553 TACHYCARDIA 3 0.0000
554 URINARY INCONTINENCE 1 0.0000
555 JOINT SWELLING 4 0.0000
556 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
557 STOMATITIS 2 0.0000
558 ILL-DEFINED DISORDER 2 0.0000
559 INJECTION SITE RASH 1 0.0000
560 DRUG ADMINISTRATION ERROR 1 0.0000
561 EMOTIONAL DISORDER 1 0.0000
562 CHEST PAIN 6 0.0000
563 VISUAL IMPAIRMENT 4 0.0000
564 FATIGUE 25 0.0000
565 VOMITING 15 0.0000
566 NEUROPATHY PERIPHERAL 3 0.0000
567 CYSTITIS 1 0.0000
568 METABOLIC ACIDOSIS 1 0.0000
569 MOVEMENT DISORDER 1 0.0000
570 PAIN IN EXTREMITY 9 0.0000
571 EYE DISORDER 1 0.0000
572 TREMOR 5 0.0000
573 URINARY RETENTION 1 0.0000
574 GAIT INABILITY 1 0.0000
575 TYPE 2 DIABETES MELLITUS 1 0.0000
576 FLUSHING 3 0.0000
577 PRODUCT QUALITY ISSUE 4 0.0000
578 HAEMATURIA 1 0.0000
579 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
580 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
581 EPISTAXIS 2 0.0000
582 INTESTINAL OBSTRUCTION 1 0.0000
583 CHILLS 3 0.0000
584 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
585 ABNORMAL BEHAVIOUR 1 0.0000
586 DISORIENTATION 1 0.0000
587 INJECTION SITE HAEMORRHAGE 2 0.0000
588 COUGH 7 0.0000
589 THROMBOSIS 2 0.0000
590 SOMNOLENCE 5 0.0000
591 EXTRA DOSE ADMINISTERED 1 0.0000
592 PSORIATIC ARTHROPATHY 1 0.0000
593 BLINDNESS 1 0.0000
594 NEUTROPHIL COUNT DECREASED 1 0.0000
595 OSTEOPOROSIS 1 0.0000
596 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
597 CARDIO-RESPIRATORY ARREST 1 0.0000
598 RENAL IMPAIRMENT 2 0.0000
599 OSTEOARTHRITIS 1 0.0000
600 RECTAL HAEMORRHAGE 1 0.0000
601 HYPOACUSIS 1 0.0000
602 DEVICE LEAKAGE 1 0.0000
603 MENTAL DISORDER 1 0.0000
604 LIVER DISORDER 1 0.0000
605 COLITIS ULCERATIVE 1 0.0000
606 WEIGHT INCREASED 5 0.0000
607 DEVICE ISSUE 2 0.0000
608 DEPRESSION 5 0.0000
609 VISION BLURRED 3 0.0000
610 MUSCLE SPASMS 4 0.0000
611 TINNITUS 1 0.0000
612 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
613 OROPHARYNGEAL PAIN 2 0.0000
614 RENAL DISORDER 1 0.0000
615 CARDIAC DISORDER 2 0.0000
616 FALL 7 0.0000
617 PRODUCTIVE COUGH 1 0.0000
618 BLOOD GLUCOSE DECREASED 1 0.0000
619 CELLULITIS 1 0.0000
620 HAEMOGLOBIN DECREASED 2 0.0000
621 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
622 MUSCULOSKELETAL PAIN 1 0.0000
623 DEPRESSED MOOD 1 0.0000
624 DRUG INTERACTION 3 0.0000
625 CONFUSIONAL STATE 3 0.0000
626 DISTURBANCE IN ATTENTION 1 0.0000
627 OEDEMA 1 0.0000
628 SEPSIS 2 0.0000
629 WEIGHT DECREASED 5 0.0000
630 CEREBROVASCULAR ACCIDENT 3 0.0000
631 NAUSEA 14 0.0000
632 ANXIETY 5 0.0000
633 INCORRECT DOSE ADMINISTERED 4 0.0000
634 HERPES ZOSTER 1 0.0000
635 OFF LABEL USE 15 0.0000
636 COVID-19 3 0.0000
637 BONE PAIN 1 0.0000
638 DIARRHOEA 11 0.0000
639 EMOTIONAL DISTRESS 2 0.0000
640 OEDEMA PERIPHERAL 2 0.0000
641 VERTIGO 1 0.0000
642 DISCOMFORT 1 0.0000
643 PRODUCT DOSE OMISSION 1 0.0000
644 RENAL FAILURE 2 0.0000
645 DEHYDRATION 2 0.0000
646 HYPOTENSION 3 0.0000
647 INJECTION SITE REACTION 1 0.0000
648 DEVICE MALFUNCTION 1 0.0000
649 SLEEP DISORDER 1 0.0000
650 THERAPY INTERRUPTED 1 0.0000
651 MOBILITY DECREASED 1 0.0000
652 CONSTIPATION 3 0.0000
653 AGITATION 1 0.0000
654 DYSGEUSIA 1 0.0000
655 INJECTION SITE BRUISING 1 0.0000
656 PROSTATE CANCER 1 0.0000
657 DRUG DOSE OMISSION 2 0.0000
658 TOXICITY TO VARIOUS AGENTS 2 0.0000
659 MYOCARDIAL INFARCTION 2 0.0000
660 PRODUCT STORAGE ERROR 1 0.0000
661 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
662 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
663 NO ADVERSE EVENT 2 0.0000
664 SUICIDAL IDEATION 1 0.0000
665 DYSPHAGIA 1 0.0000
666 PULMONARY EMBOLISM 1 0.0000
667 ANAEMIA 2 0.0000
668 ATRIAL FIBRILLATION 1 0.0000
669 PRODUCT DOSE OMISSION ISSUE 3 0.0000
670 DYSPEPSIA 1 0.0000
671 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
672 CHEST DISCOMFORT 1 0.0000
673 SINUSITIS 1 0.0000
674 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
675 MUSCULAR WEAKNESS 1 0.0000
676 LOSS OF CONSCIOUSNESS 1 0.0000
677 NEUTROPENIA 1 0.0000
678 INJECTION SITE PAIN 2 0.0000
679 HOSPITALISATION 1 0.0000
680 ABDOMINAL PAIN 1 0.0000